Psychiatry and Neurology, Neurology · Harlingen, TX
NPI
1114375359
Since 2016
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2902 Haine Drive, 3.144.06
Harlingen, TX, 78550
Phone (956) 296-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$712K
17,898 services
Medicare patients, 2024
139
Average age 69
Drug cost, 2024
$2.6M
1,681 prescriptions
Company payments, 2025
$1,893
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francisco P Gomez was code J2350 (injection, ocrelizumab, 1 mg), 13,200 times for 13 patients. In total Francisco P Gomez billed 17,898 services in 21 codes, and Medicare paid $712K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2350 Injection, ocrelizumab, 1 mg | Office | 13,200 | 13 | $46.79 | $618K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,525 | 17 | $0.23 | $347 |
| 99215 Office E&M - Established | Office | 124 | 88 | $125.39 | $16K |
| 99214 Office E&M - Established | Office | 108 | 82 | $83.57 | $9,026 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 86 | 35 | $24.30 | $2,090 |
| 99205 Office E&M - New | Office | 36 | 35 | $154.55 | $5,564 |
| 96413 Chemotherapy Administration | Office | 35 | 17 | $85.05 | $2,977 |
| 96375 Injection Administration | Office | 32 | 16 | $9.25 | $296 |
| 96415 Chemotherapy Administration | Office | 30 | 15 | $18.53 | $556 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 30 | 16 | $0.55 | $16.6 |
| 96367 Intravenous Infusion, Hydration | Office | 27 | 16 | $17.13 | $462 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 16 | 16 | $11.02 | $176 |
| 99443 Telephone Services | Office | 13 | 13 | $97.98 | $1,274 |
By year: 2022 $14K for 159 services; 2023 $231K for 5,065 services; 2024 $712K for 17,898 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francisco P Gomez prescribed most often to Medicare patients was Gabapentin, with 145 prescriptions and refills. In total Francisco P Gomez wrote 1,681 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 145 | 307 | 44 | $3,792 |
| Baclofen Generic | 128 | 296 | 40 | $4,273 |
| Dalfampridine Er Dalfampridine | 77 | 131 | 18 | $48K |
| Teriflunomide Generic | 67 | 75 | Under 11 | $227K |
| Memantine Hcl Generic | 55 | 108 | 19 | $1,049 |
| Glatiramer Acetate Generic | 48 | 56 | Under 11 | $180K |
| Clonazepam Generic | 48 | 50 | 12 | $198 |
| Donepezil Hcl Generic | 44 | 94 | 17 | $462 |
| Alprazolam Generic | 40 | 40 | Under 11 | $188 |
| Duloxetine Hcl Generic | 38 | 100 | 13 | $975 |
| Pregabalin Generic | 34 | 73 | Under 11 | $984 |
| Fingolimod Fingolimod Hcl | 33 | 35 | Under 11 | $90K |
| Kesimpta Pen Ofatumumab | 33 | 40 | Under 11 | $430K |
| Nurtec Odt Rimegepant Sulfate | 32 | 32 | Under 11 | $62K |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 30 | 30 | Under 11 | $310 |
Brand drugs: 250 claims; generic drugs: 1,431 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francisco P Gomez $1,893 ($1,893 in general payments such as food, travel and fees) from 15 companies. The largest payer was TG Therapeutics, Inc. with $602.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 8 | $602 |
| EMD Serono, Inc. MRK.DE | 4 | $262 |
| LivaNova USA, Inc. LIVN | 2 | $197 |
| Argenx US, Inc. ARGX | 2 | $197 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $125 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $124 |
| Eisai Inc. 4523.T | 1 | $124 |
| Biogen, Inc. BIIB | 1 | $92 |
| SpringWorks Therapeutics, Inc. | 1 | $56.52 |
| Celgene Corporation BMY | 1 | $24.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.